The Circuit Court of Appeals for the District of Columbia decided Tuesday afternoon to allow federally funded human embryonic stem cell research to continue, while the federal government appeals a lower court injunction that barred the work.
Recent Posts
- CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
- Stem cell therapy linked to lower risk of heart failure after a heart attack
- Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
- Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
- New UCLA drug could restore heart and organ function
- Parkinson’s treatment tested at UW showing promise in first clinical trial
